TipRanks
Advertisement
Advertisement
Eli Lilly price target raised to $940 from $850 at HSBC
PremiumThe FlyEli Lilly price target raised to $940 from $850 at HSBC
5d ago
Option traders moderately bearish in Eli Lilly with shareslittle changed
Premium
The Fly
Option traders moderately bearish in Eli Lilly with shareslittle changed
13d ago
Eli Lilly Buy Rating Reiterated as Analyst Sees Multi‑Year Growth Upside, Maintains $1,400 December 2026 Price Target
Premium
Ratings
Eli Lilly Buy Rating Reiterated as Analyst Sees Multi‑Year Growth Upside, Maintains $1,400 December 2026 Price Target
13d ago
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
PremiumTipRanks NewswireEntera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
15d ago
Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA
Premium
The Fly
Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA
15d ago
Eli Lilly to acquire Merida Biosciences for $2.88B in cash
Premium
The Fly
Eli Lilly to acquire Merida Biosciences for $2.88B in cash
15d ago
PepsiCo ending coverage for prescription weight-loss drugs, Bloomberg reports
PremiumThe FlyPepsiCo ending coverage for prescription weight-loss drugs, Bloomberg reports
21d ago
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
Premium
The Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
21d ago
Eli Lilly Buy Rating Reiterated on Durable Incretin and Obesity Growth, Price Target Maintained at $1,344
Premium
Ratings
Eli Lilly Buy Rating Reiterated on Durable Incretin and Obesity Growth, Price Target Maintained at $1,344
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100